Gabi Tarcic insider trades

Open-market stock purchases and sales by Gabi Tarcic, Chief Development Officer at Evogene Ltd, from SEC Form 4 filings since Jun 4, 2026.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -37%.

Recent trades

DateStockTradeValue
Jun 4, 2026EVGN Evogene LtdBought$677

Companies traded

  • EVGN Evogene Ltd: 1 buy, last Jun 4, 2026

Get free alerts when Gabi Tarcic files a new trade →